Correction: Eevia Health’s Board of Directors has resolved, subject to approval at an Extraordinary General Meeting, on a directed share issue of SEK 20 million
This is a correction to press release published 10 November, 2021 where the press release lacked a reference to the EU´s Market Abuse Regulation (MAR). The Board of Directors of Eevia Health Plc (publ) (“Eevia” or the “Company”) has resolved, subject to the approval by shareholders at an Extraordinary General Meeting (the “EGM”), on a directed new issue of 2,061,856 shares at a subscription price of SEK 9.70 per share (the “Directed Share Issue”), which is expected to raise proceeds to the Company of SEK 20 million before issue costs. The proceeds will primarily be used for investments in